{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:03:49Z","timestamp":1769011429223,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejim.2023.11.022","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T20:29:58Z","timestamp":1701116998000},"page":"29-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["When the responsibility for a crime is shared between several actors. The case of hypertensive heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"120","author":[{"given":"Stefano","family":"Coiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-8936","authenticated-orcid":false,"given":"Paolo","family":"Verdecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4925-7985","authenticated-orcid":false,"given":"Fabio","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2023.11.022_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.10.008","article-title":"The current best drug treatment for hypertensive heart failure with preserved ejection fraction","volume":"120","author":"Rist","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2023.11.022_bib0002","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/HJH.0000000000002910","article-title":"Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension","volume":"39","author":"Kasiakogias","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2023.11.022_bib0003","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2023.11.022_bib0004","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jchf.2020.04.005","article-title":"Diagnostic Algorithms for heart failure with preserved ejection fraction","volume":"8","author":"Nagueh","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejim.2023.11.022_bib0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension","volume":"72","author":"Gonz\u00e1lez","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.11.022_bib0006","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.11.022_bib0007","first-page":"e895","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.11.022_bib0008","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.11.022_bib0009","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2023.11.022_bib0010","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2023.11.022_bib0011","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.11.022_bib0012","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ejhf.1060","article-title":"Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial","volume":"20","author":"Selvaraj","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2023.11.022_bib0013","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2020.02.009","article-title":"Systolic blood pressure in heart failure with preserved ejection fraction treated with sacubitril\/valsartan","volume":"75","author":"Selvaraj","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2023.11.022_bib0014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jchf.2022.09.002","article-title":"Blood pressure and dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: DELIVER","volume":"11","author":"Selvaraj","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejim.2023.11.022_bib0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/eurheartj\/ehac693","article-title":"Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial","volume":"44","author":"Bhm","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.11.022_bib0016","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/HJH.0000000000002807","article-title":"Association of long-term SBP with clinical outcomes and quality of life in heart failure with preserved ejection fraction: an analysis of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"39","author":"Huang","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2023.11.022_bib0017","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamacardio.2017.5365","article-title":"Systolic blood pressure and outcomes in patients with heart failure with preserved ejection fraction","volume":"3","author":"Tsimploulis","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2023.11.022_bib0018","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41440-019-0216-8","article-title":"Effects of blood pressure lowering in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"42","author":"Kawano","year":"2019","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ejim.2023.11.022_bib0019","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/HCO.0000000000000852","article-title":"Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?","volume":"36","author":"Myhre","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ejim.2023.11.022_bib0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2023.11.022_bib0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(16)30669-9","article-title":"Blood pressure lowering for cardiovascular disease - authors' reply","volume":"388","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2023.11.022_bib0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11906-020-01093-7","article-title":"Hypertension as a road to treatment of heart failure with preserved ejection fraction","volume":"22","author":"Hicklin","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ejim.2023.11.022_bib0023","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523004193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523004193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:39:00Z","timestamp":1715899140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523004193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"alternative-id":["S0953620523004193"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.11.022","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When the responsibility for a crime is shared between several actors. The case of hypertensive heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}